Full-Time
Confirmed live in the last 24 hours
Produces synthetic DNA for biotechnology applications
$124.7k - $141k/yr
Mid, Senior
San Bruno, CA, USA
Hybrid position requiring in-office presence in South San Francisco, CA.
Twist Bioscience specializes in the synthesis of synthetic DNA, which is essential for various applications in biotechnology, pharmaceuticals, and research. The company produces high-quality DNA sequences that clients, including academic institutions and pharmaceutical companies, use for drug development, disease diagnosis, and genetic research. Twist Bioscience differentiates itself by offering competitive pricing and a proprietary platform that enables quick and accurate DNA production. This platform uses an algorithm to provide instant feedback on the synthesizability of DNA sequences. Their product range includes genes, oligo pools, variant libraries, and tools for SARS-CoV-2, along with DNA data storage and next-generation sequencing services. The company's goal is to be a leading supplier in the synthetic biology market, providing thousands of genes rapidly and supporting complex research projects.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
South San Francisco, California
Founded
2013
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Disability Insurance
Life Insurance
401(k) Retirement Plan
Atlas has secured a $155 million seed funding round, backed by family offices Tao Capital Partners and Bezos Expeditions, along with ARCH Venture Partners, Deerfield Management, Rsquared VC, Earth Foundry, In-Q-Tel, and others. This investment highlights confidence in Atlas's DNA-based data storage technology. Atlas has also acquired DNA storage assets from Twist Bioscience, positioning it as a leader in the field with its proprietary platform combining semiconductor and enzyme engineering.
Twist Bioscience launches Atlas to bring DNA storage to market.
Twist Bioscience has launched Atlas Data Storage as an independent company focused entirely on the development and commercialization of DNA data storage technologies.
Twist Bioscience named a Best Idea for 2025 at TD Cowen.
Absci, a pioneer in generative AI-driven drug discovery, and Twist Bioscience, a leader in high-quality synthetic DNA production through its silicon platform, have announced an innovative collaboration to create a novel therapeutic antibody using generative AI.